ZA97170B - Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment of prophylaxis of menopausal symptoms. - Google Patents

Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment of prophylaxis of menopausal symptoms.

Info

Publication number
ZA97170B
ZA97170B ZA9700170A ZA97170A ZA97170B ZA 97170 B ZA97170 B ZA 97170B ZA 9700170 A ZA9700170 A ZA 9700170A ZA 97170 A ZA97170 A ZA 97170A ZA 97170 B ZA97170 B ZA 97170B
Authority
ZA
South Africa
Prior art keywords
prophylaxis
manufacture
treatment
pharmaceutical composition
menopausal symptoms
Prior art date
Application number
ZA9700170A
Inventor
Michael Shalmi
Niels Korsgaard
Birgitte Hjort Guldhammer
James Robertson Piggott
Virender Mohan Labroo
Steven Bain
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of ZA97170B publication Critical patent/ZA97170B/en

Links

ZA9700170A 1996-01-11 1997-01-09 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment of prophylaxis of menopausal symptoms. ZA97170B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US983496P 1996-01-11 1996-01-11

Publications (1)

Publication Number Publication Date
ZA97170B true ZA97170B (en) 1997-09-09

Family

ID=21739983

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9700170A ZA97170B (en) 1996-01-11 1997-01-09 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment of prophylaxis of menopausal symptoms.

Country Status (1)

Country Link
ZA (1) ZA97170B (en)

Similar Documents

Publication Publication Date Title
ZA979220B (en) New oxadiazoles, processes for their preparation and their use as pharmaceutical compositions.
HUP9902683A3 (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of menopausal symptoms
AU4060599A (en) Pharmaceutical composition for treating or preventing sleep disorders
HUP0003265A3 (en) Nutritional composition for the treatment of pressure ulcers
HUP9702244A3 (en) Use of 3,4-diphenyl chromans for manufacture of a pharmaceutical composition for treatment or prophylaxis of gynaecological disorders
ZA9710071B (en) Pharmaceutical composition.
ZA974735B (en) Pharmaceutical compositions.
AU1367597A (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of benign prostatic hypertrophy
AU1367397A (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of atrophy of skin and/or mucous membranes
HUP9702246A3 (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of degenerative cerebral disorders
IL116745A0 (en) Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions
HUP9800334A3 (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of obesity
ZA972602B (en) Pharmaceutical compositions.
ZA976171B (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for inhibiting one or more symptoms of premenstrual syndrome.
ZA97170B (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment of prophylaxis of menopausal symptoms.
AU7845098A (en) Pharmaceutical compositions comprising a 4-arylcoumarin for the treatment f vir al infections
AU4329196A (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for vasodilatory treatment or prophylaxis
HUP9800133A3 (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment of prophylaxis of idiopathic or physiologic gynaecomastia
ZA98681B (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for inhibition senescense-associated motor impairment
ZA976170B (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for lowering intraocular pressure.
ZA98682B (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for inhibiting one or more psychiatric disorders
ZA97168B (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment of prophylaxis of prostatic carcinoma
ZA96446B (en) Use of 3,4-diphenyl chromans for the manufacture of pharmaceutical composition for the treatment or prophylaxis of obesity
ZA96440B (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for vasodilatory treatment or prophylaxis
AU4756697A (en) Use of 8,9-dehydroestrone for the manufacture of a medicament for the treatment of vasomotor symptoms